March/April 2015
Table of Contents
- Hepatitis C virus
- Grazoprevir + elbasvir and other emerging drugs
- Enter ledipasvir
- Sirius—ledipasvir + sofosbuvir in cases of severe liver injury
- Using ledipasvir + sofosbuvir when prior treatment with sofosbuvir failed
- Grading severe liver disease and predicting survival
- Ledipasvir + sofosbuvir with or without ribavirin in people with liver transplants
- Solar-1—ledipasvir + sofosbuvir in people with symptoms of severe liver injury
- Ledipasvir + sofosbuvir with or without ribavirin in compensated cirrhosis
- Ledipasvir + sofosbuvir in HCV genotype 6—a pilot study
- Ledipasvir + sofosbuvir in HIV co-infection